about
Conditional survival of pancreatic ductal adenocarcinoma in surgical and nonsurgical patients: a retrospective analysis report from a single institution in ChinaPreoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report.High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinomaSystemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery.Decreased expression of GATA2 promoted proliferation, migration and invasion of HepG2 in vitro and correlated with poor prognosis of hepatocellular carcinoma.Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China.Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma.Endotoxin Tolerance Inhibits Degradation of Tumor Necrosis Factor Receptor-Associated Factor 3 by Suppressing Pellino 1 Expression and the K48 Ubiquitin Ligase Activity of Cellular Inhibitor of Apoptosis Protein 2.Preventive Inhibition of Liver Tumorigenesis by Systemic Activation of Innate Immune Functions.ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.The SMAC mimetic birinapant attenuates lipopolysaccharide-induced liver injury by inhibiting the tumor necrosis factor receptor-associated factor 3 degradation in Kupffer cells.[Analysis of prognostic factors of patients with hepatocellular carcinoma after radical resection].Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative ResectionPlatelet count on preoperative day 1 predicts the long-term responses to laparoscopic splenectomy for Chinese patients with medically refractory idiopathic thrombocytopenic purpuraCombined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative HepatectomyFatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinomaAn imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrenceLetter to the Editor: Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: Benefit or NotPIAS4, upregulated in hepatocellular carcinoma, promotes tumorigenicity and metastasisA Nomogram Predicting Microvascular Invasion Risk in BCLC 0/A Hepatocellular Carcinoma after Curative Resection
P50
Q35737695-2E6AF484-4BE2-460F-A90C-8DFA2B5F0D11Q36019935-05D08A30-E62C-4871-95AA-01C43535DD4BQ36753243-465BB55A-27F0-4D27-82D3-145744119066Q37327632-33AD7BF9-A38C-441A-9E97-78149882A244Q37534541-7FE3F935-9551-43FE-9A34-B39CD8504F5EQ37702167-300E86E8-C27E-4098-BA01-444EB1EDC690Q38491431-EF40FE1D-91DC-41B5-A61A-16D2580EF32EQ39100773-A5B0A65A-2A47-4C6C-87BE-46F7C0933531Q40526689-6A96809F-DC2D-4AA5-A928-FC1E87F7F55CQ40625696-0B5CE3D9-6F39-48D0-B4C4-3BC3CE84F3B6Q46232926-4C112A8F-E56D-4182-B369-CD4706461795Q50550515-642BB772-93D6-49F9-B4C5-CCB3DDB45B05Q50848518-15309216-508E-4560-A014-E1E5F0E96498Q51019073-4A20C8BB-72CB-4ECF-AAC1-9EBA0FD3502DQ52658496-FFFC13CA-DD67-4785-9BB8-7586E4695567Q57492763-5627C735-81F5-41FC-8B7B-99F188BF5F4AQ59808505-DF891D5D-388C-44B3-BECD-2779EE33D66CQ88733788-3B7DD534-44C1-425B-8343-0D47393F1F60Q89345863-4EF22331-C735-4CB6-A175-EED1ADF548B9Q92161340-CA2DDC06-CB7E-448D-BFE2-4A2E1DDECD7FQ92170129-A63D6BFD-C088-4A92-80CF-83582B57C0B5Q92676821-DBD623DF-2606-4083-8FC6-A6F4772112EEQ92716102-BEB1636B-22F4-4342-9CBD-EBE2E1191AC8
P50
description
investigador
@es
researcher
@en
name
Rui Liao
@en
type
label
Rui Liao
@en
prefLabel
Rui Liao
@en
P31
P496
0000-0002-0057-2792